Cochrane Abstracts
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ataluren and Similar Compounds (specific Therapies for Premature Termination Codon Class I Mutations) for Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Ataluren_and_similar_compounds__specific_therapies_for_premature_termination_codon_class_I_mutations__for_cystic_fibrosis.
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Ataluren_and_similar_compounds__specific_therapies_for_premature_termination_codon_class_I_mutations__for_cystic_fibrosis. Accessed January 20, 2025.
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Ataluren_and_similar_compounds__specific_therapies_for_premature_termination_codon_class_I_mutations__for_cystic_fibrosis
Ataluren and Similar Compounds (specific Therapies for Premature Termination Codon Class I Mutations) for Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Ataluren_and_similar_compounds__specific_therapies_for_premature_termination_codon_class_I_mutations__for_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis
ID - 434509
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Ataluren_and_similar_compounds__specific_therapies_for_premature_termination_codon_class_I_mutations__for_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
